Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.

Volume 2 (2005), Issue 2 (February)

1. Radiation therapy in cancer patients with psoriasis. The fractionated daily dose and the Koebner phenomenon.
   Radiother Oncol, 74(1): 21-3. [Abstract] [Full-text]
2. Psoriasis: emerging therapeutic strategies.
   Nat Rev Drug Discov, 4(1): 19-34. [Abstract] [Full-text]
3. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression.
   J Am Acad Dermatol, 52(2): 24-7. [Abstract] [Full-text]
4. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
   J Am Acad Dermatol, 52(2): 262-7. [Abstract] [Full-text]
5. Identification of human hornerin and its expression in regenerating and psoriatic skin.
   J Biol Chem, 280(6): 4696-703. [Abstract] [Full-text]
6. The burden of illness associated with psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
   Curr Med Res Opin, 20(12): 1929-36. [Abstract] [Full-text]
7. The combination of the Zenon labeling technique and microscopic image analysis to study cell populations in normal and psoriatic epidermis.
   J Cutan Pathol, 32(3): 212-9. [Abstract] [Full-text]
8. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris.
   Proc Natl Acad Sci U S A, 102(6): 2075-80. [Abstract] [Full-text]
9. Psoriatic arthritis and psoriasis: role of patient advocacy organisations in the twenty first century.
   Ann Rheum Dis, 64: ii93-100. [Abstract] [Full-text]
10. Psoriasis treatment: current and emerging directed therapies.
    Ann Rheum Dis, 64: ii87-90; discussion ii91-2. [Abstract] [Full-text]
11. Psoriasis treatment: traditional therapy.
    Ann Rheum Dis, 64: ii83-6. [Abstract] [Full-text]
12. Psoriatic arthritis treatment: biological response modifiers.
    Ann Rheum Dis, 64: ii78-82. [Abstract] [Full-text]
13. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.
    Ann Rheum Dis, 64: ii74-7. [Abstract] [Full-text]
14. Psoriasis assessment tools in clinical trials.
    Ann Rheum Dis, 64: ii65-8; discussion ii69-73. [Abstract] [Full-text]
15. Psoriatic arthritis imaging: a review of scoring methods.
    Ann Rheum Dis, 64: ii61-4. [Abstract] [Full-text]
16. Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis.
    Ann Rheum Dis, 64: ii58-60. [Abstract] [Full-text]
17. Psoriatic arthritis and imaging.
    Ann Rheum Dis, 64: ii55-7. [Abstract] [Full-text]
18. Psoriatic arthritis assessment tools in clinical trials.
    Ann Rheum Dis, 64: ii49-54. [Abstract] [Full-text]
19. Ethical and practical issues in conducting clinical trials in psoriasis and psoriatic arthritis.
    Ann Rheum Dis, 64: ii46-8. [Abstract] [Full-text]
20. Science of assessment.
    Ann Rheum Dis, 64: ii42-5. [Abstract] [Full-text]
21. Genetic epidemiology of psoriasis and psoriatic arthritis.
    Ann Rheum Dis, 64: ii37-9; discussion ii40-1. [Abstract] [Full-text]
22. Psoriasis pathophysiology: current concepts of pathogenesis.
    Ann Rheum Dis, 64: ii30-6. [Abstract] [Full-text]
23. Classification and diagnostic criteria for psoriatic arthritis.
    Ann Rheum Dis, 64: ii3-8. [Abstract] [Full-text]
24. Immunopathology of psoriasis and psoriatic arthritis.
    Ann Rheum Dis, 64: ii26-9. [Abstract] [Full-text]
25. Psoriasis: epidemiology, clinical features, and quality of life.
    Ann Rheum Dis, 64: ii18-23; discussion ii24-5. [Abstract] [Full-text]
26. Psoriatic arthritis: epidemiology, clinical features, course, and outcome.
    Ann Rheum Dis, 64: ii14-7. [Abstract] [Full-text]
27. OMERACT 7 psoriatic arthritis workshop: synopsis.
    Ann Rheum Dis, 64: ii115-6. [Abstract] [Full-text]
28. Consensus exercise on domains in psoriatic arthritis.
    Ann Rheum Dis, 64: ii113-4. [Abstract] [Full-text]
29. Preliminary identification of core domains for outcome studies in psoriatic arthritis using Delphi methods.
    Ann Rheum Dis, 64: ii110-2. [Abstract] [Full-text]
30. Psoriasis clinical registries, genetics, and genomics.
    Ann Rheum Dis, 64: ii106-7. [Abstract] [Full-text]
31. Psoriatic arthritis clinical registries and genomics.
    Ann Rheum Dis, 64: ii103-5. [Abstract] [Full-text]
32. Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts.
    J Autoimmun, 24(1): 69-78. [Abstract] [Full-text]
33. Serum immunoglobulins in psoriatic erythroderma.
    Clin Exp Dermatol, 30(2): 125-7. [Abstract] [Full-text]
34. Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life.
    Br J Dermatol, 152(2): 289-95. [Abstract] [Full-text]
35. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study.
    Br J Dermatol, 152(2): 279-83. [Abstract] [Full-text]

© 2004-2008 Psoriasis Research Today. All Rights Reserved.